SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120341
Filing Date
2016-05-12
Accepted
2016-05-12 11:01:58
Documents
73
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-10488_110q.htm 10-Q 1161926
2 EX-31.1 a16-10488_1ex31d1.htm EX-31.1 10013
3 EX-31.2 a16-10488_1ex31d2.htm EX-31.2 9962
4 EX-32.1 a16-10488_1ex32d1.htm EX-32.1 5325
5 EX-32.2 a16-10488_1ex32d2.htm EX-32.2 5359
  Complete submission text file 0001104659-16-120341.txt   4695226

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adap-20160331.xml EX-101.INS 925110
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adap-20160331.xsd EX-101.SCH 46781
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adap-20160331_cal.xml EX-101.CAL 39891
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adap-20160331_def.xml EX-101.DEF 88311
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT adap-20160331_lab.xml EX-101.LAB 318827
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adap-20160331_pre.xml EX-101.PRE 271479
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 161642250
SIC: 2836 Biological Products, (No Diagnostic Substances)